Objective. We compared patient characteristics, dialysis practice patterns and outcomes of peritoneal dialysis (PD) patients between one Chinese centre and one Canadian centre to determine whether observed differences in demographics and practices are associated with patient and technique survival. Methods. This study included all patients who started on PD between
Introduction
Outcomes among dialysis patients differ considerably between and within countries. Held et al. reported that, adjusted for age and diabetes, the mortality risk for the endstage renal disease (ESRD) patients in the United States was 15% higher than in European patients and 33% higher than in Japanese patients [1] . Furthermore, after adjusting for age, gender, race and 25 comorbid conditions, Goodkin et al. reported that, compared to Japanese patients, the relative risk of mortality in haemodialysis (HD) patients in Europe was 2.84 and 3.78 for the United States [2] . The basis for and implications of this survival difference continues to be debated. In peritoneal dialysis (PD), on the other hand, Chung et al. compared survival between 106 Swedish and 132 Korean patients with a median follow-up of 18 months, and found no difference in patient outcome, both unadjusted and after adjusting for some patient and centre characteristics [3] .
Survival on dialysis is affected by both treatment and patient characteristics. To date, we do not have international studies of long-term survival on PD containing extensive profiles of patient characteristics and outcomes. Therefore, we compared the patient characteristics, PD practice patterns and outcomes between two experienced university centres, one in China and one in Canada, to determine whether and to what extent these differences are associated 4022 W. Fang et al. with patient and technique survival. We believe that this study will provide evidence that may improve treatment of PD patients in both countries.
Materials and methods

Patients and data collection
All patients who started on PD between 1 January 2000 and 31 December 2004 at the University Health Network, University of Toronto, Canada, and Renji Hospital, Shanghai Jiao Tong University School of Medicine, China, were identified from administrative records. Data were collected regarding patient demographic characteristics, comorbid diseases, laboratory values and medical history. All deaths, switches to HD, transplantation, peritonitis episodes and other patient outcomes were carefully tracked and recorded.
We recorded data of initiation of dialysis, including age, gender, race (White, Asian, Black or other), height, weight, underlying cause of ESRD, date of initiation of dialysis, PD prescription (including PD volume and PD modality) and presence of comorbid diseases such as diabetes mellitus and cardiovascular disease (CVD) at the time of initiation of PD. Diabetes mellitus was defined either as a comorbid condition or as the aetiology of ESRD. CVD was defined as a previous history of coronary artery disease, peripheral vascular disease or cerebrovascular disease. Body mass index (BMI) was calculated as the weight (kg) divided by the square of height in metres [BMI = weight (kg)/height (m 2 )]. Blood pressure was measured by trained staff with a standard mercury sphygmomanometer. We collected baseline systolic and diastolic blood pressures and number of antihypertensive medications.
Dialysis adequacy data, namely indices of urea kinetics (Kt/Vurea) and creatinine clearance (CrCl) for both peritoneal and residual renal function (RRF), were documented using standard methods. Peritoneal transport characteristics were measured by the dialysate-to-plasma creatinine ratio (D/Pcr) at 4 h in a standard peritoneal equilibration test (PET). RRF, urine output and net effluent volumes were recorded. RRF was estimated by calculating the mean of renal clearances of urea and creatinine from a 24-h urine collection. Nutritional status was assessed by normalized protein catabolic rate (nPCR) from 24-h dialysate and urine collections. At the initiation of PD, the following laboratory parameters were also collected: haemoglobin, serum albumin, calcium, phosphate and intact parathyroid hormone (iPTH).
The total number of episodes of peritonitis and date of every episode of peritonitis were collected. For both centres, peritonitis rates were calculated by dividing the months of PD at risk by the number of episodes.
Detailed causes of death and transfer to HD were recorded from the clinical charts. Causes of death were grouped in broad categories as follows: cardiovascular, including cardiac, cerebrovascular, peripheral vascular and sudden death; infection, including peritonitis, pneumonia and other infections; other and unknown causes. Causes of switch to HD were grouped into peritonitis; catheterrelated events including leak, hernia and catheter malposition; inadequate dialysis, including ultrafiltration failure/fluid management issues and other medical causes. All patients were followed up from the date of PD initiation until death, cessation of PD, transfer to other centres or to the end of the study (31 December 2006) .
Statistical analyses
All results were expressed as mean ± SD for normally distributed data, median and range for skewed data and frequency (%) for categorical data. Differences in patient demographic, clinical and laboratory parameters between two centres were evaluated by Student's t-test for parametric data and the Mann-Whitney test for nonparametric data. Comparisons of percentages between groups were made with the chi-square test (χ 2 ) or Fisher's exact test, as appropriate.
Actuarial cumulative survival rates were determined by using life table analysis. Survival curves were generated by the Kaplan-Meier method and compared by the log-rank test. Risk factors associated with mortality and technique failure were determined by univariate and then by a multivariate Cox proportional hazards model. A backward stepwise elimination multivariate Cox modelling analysis was performed to determine the independent predictors of patient outcome, and only covariates that remained significant (P < 0.05) were kept in the model. Data were censored at the following events: death, switch to HD, renal transplantation, transfer to other centre, recovery of renal function and loss to follow-up, with the exception of death for patient survival analysis, and the exception of switch to HD for death-censored technique calculation. In order to avoid the risk that patients doing poorly on PD and switched to HD as a pre-terminal event, we categorized patients who died within 3 months after being switched to HD as death on PD, and in this case, data were censored at the date of death for patient survival analysis. Also, time to the first peritonitis episode was examined using the Kaplan-Meier method and Cox regression models for multivariate analyses. Statistical analysis was performed using SPSS for Windows software, version 13.0 (SPSS Inc., Chicago, IL, USA). A P-value <0.05 was considered statistically significant.
Results
Demographic and clinical characteristics
A total of 496 patients were included, 256 from the Canadian centre and 240 from the Chinese centre. The main baseline demographic and clinical characteristics of the study populations are presented in Canadian patients at the commencement of PD, and they were prescribed more antihypertensive medications. Laboratory data showed that, compared to Canadian patients, Chinese patients were more anaemic, had lower serum albumin, marginally lower corrected calcium, higher serum phosphate and iPTH at the time of PD initiation.
PD prescription and adequacy data
At the initiation of PD, Canadian patients had greater RRF than their Chinese counterparts (6.77 ± 4.43 versus 3.52 ± 2.67 ml/min, P < 0.001). They had a higher D/P creatinine ratio at 4 h in a standard PET (0.71 ± 0.09 versus 0.68 ± 0.13, P < 0.01) and were treated with significantly higher volumes of dialysis fluid than the Chinese patients (median 8.0 l versus 6.0 l, P < 0.001). The comparison of adequacy data showed that, compared with Chinese patients, Canadian patients had higher peritoneal Kt/Vurea, renal Kt/Vurea, peritoneal CrCl, renal CrCl and ultrafiltration whereas Chinese patients had higher urine output despite the lower RRF. There was no difference in nPCR and total daily fluid removal (Table 2) .
In Canadian patients, after the start, the PD modality was continuous ambulatory peritoneal dialysis (CAPD) with the twin-bag system in 99 (38.7%), automated peritoneal dialysis (APD) in 157 (61.3%) and icodextrin solution was used in 77 (30.1%). In comparison, all Chinese patients were treated with CAPD with the twin-bag system and without the icodextrin solution. Both centres were using dialysis solutions from the same supplier. During the follow-up, Chinese patients continued to be treated with significantly lower PD volumes compared to their Canadian counterparts (6.0 l versus 9.5 l at 2 years and 7.0 l versus 10.0 l at 4 years, respectively, both P < 0.001).
Clinical data during the follow-up
After 2 years on PD, Chinese patients were still more anaemic than Canadian patients, whereas serum albumin and phosphate were similar between the two groups. Parathyroid hormone was lower in Chinese than Canadian patients at 2 years. Among those who were treated with PD for >4 years, Chinese patients had lower haemoglobin, higher albumin and had better control of iPTH than that of Canadian patients (Table 3) .
Outcome
With a total follow-up of 15 176 patient-months, the mean follow-up was 29. had more deaths caused by cerebrovascular disease (43.8% versus 17.2%, P = 0.026). Peritonitis accounted for more than one-half of the deaths due to infection and tended to cause more deaths in Canadian than Chinese patients (20.3% versus 9.2%, P = 0.073).
Peritonitis was the most frequent cause of technique failure in both centres (Table 5) , followed by catheter-related complications, inadequate dialysis and other medical problems. Although more Canadians were switched to HD, the distribution of different causes of technique failure was similar between the two centres. 
Patient survival and predictors of mortality
The unadjusted patient survival rates were similar in the two centres: 90%, 79%, 72% and 61% for Canadian and 90%, 79%, 71% and 64% for Chinese patients at 1, 2, 3 and 5 years, respectively. Figure 1 shows Kaplan-Meier survival curves for Canadian and Chinese patients (log rank 0.087, P = 0.768). After adjustment for age, gender, race, diabetes, BMI, CVD, RRF, serum albumin, haemoglobin and calcium × phosphate product, there is still no significant difference in mortality between Chinese patients and Canadian patients (P > 0.05). Multivariate Cox proportional hazards modelling showed that older age, CVD, lower RRF and lower serum albumin were independent predictors of increased mortality in the combined cohort. The results are summarized in Table 6 . Age, CVD and serum albumin were the significant factors that independently predicted outcome in Canadian patients, whereas age, CVD and RRF were associated with death in Chinese patients.
Death-censored technique survival and predictors of technique failure
The unadjusted death-censored technique survival rates at 1, 2, 3 and 5 years were 92%, 88%, 85% and 73% for Canadian patients and 97%, 93%, 90% and 88% for Chinese patients, respectively. Kaplan-Meier survival curves for Canadian and Chinese patients are shown in Figure 2 . Chinese patients showed better death-censored technique survival than Canadian patients (log rank 5.947, P = 0.015). The advantage of technique survival in Chinese patients persisted (HR 0.491, 95% CI 0.269-0.898, P = 0.021) after adjustments for age, gender, race, diabetes, BMI and serum albumin. The multivariable Cox regression analysis showed that Chinese centre, lower BMI, higher albumin and male gender were independent predictors of better technique survival in the combined cohort (Table 7) . We did not do further stratification of centres to avoid the potential risk of over-fitting in the multivariate model, because the total number of instances of switch to HD in either centre was low.
Peritonitis rate and predictors of peritonitis-free survival
During the study period, a total of 336 episodes of peritonitis were recorded, including 212 in Canadian patients and 124 in Chinese patients. The average peritonitis rate was one episode every 36.1 patient-months in Canadian patients and one episode every 60.6 patient-months in their Chinese counterparts. The median peritonitis-free time for Canadian patients was 34.2 months, which was significantly shorter than for Chinese patients, who had a median peritonitis-free time of 58.7 months (log rank 9.084, P = 0.003) (Figure 3 ). We further constructed a multivariate Cox proportional hazards model for the analysis of time to the first peritonitis episode. Chinese centre (HR 0.666, 95% CI 0.494-0.896, P = 0.007), higher albumin (HR 0.656, 95% CI 0.500-0.861, P = 0.002) and younger age (HR 1.128, 95% CI 1.003-1.233, P = 0.008) were found to be significantly associated with longer peritonitis-free survival among our combined cohort. After stratifying subjects according to different centres, serum albumin (HR 0.596, 95% CI 0.399-0.891, P = 0.012) was the only predictor that was associated with peritonitis-free survival in Chinese patients, whereas serum albumin (HR 0.618, 95% CI 0.423-0.904, P = 0.013), age (HR 1.162, 95% CI 1.043-1.295, P = 0.007) and BMI (HR 1.046, 95% CI 1.002-1.093, P = 0.042) were independent predictors of peritonitis-free survival in Canadian patients.
Discussion
The present study examined an extensive profile of patient characteristics, PD practice and outcomes in one Canadian and one Chinese centre. The results have allowed us to gain insights into the practice patterns as well as the potential causes for the differences in patient and technique outcomes in these two similar-sized centres. The demographic and clinical characteristics of study patients varied between the Chinese centre and Canadian centre. The Canadian patients were older, heavier and more likely to have diabetes and cardiovascular comorbidities, findings indicating that the Canadian patients were sicker and carried a heavier burden of the most important comorbid diseases that predict a poor outcome at the initiation of PD. Chinese patients showed significantly lower RRF at the start of PD, suggesting that dialysis was commenced later in the Chinese patients. Consistent with the later commencement, Chinese patients showed a more adverse metabolic profile. However, after PD initiation, the clinical characteristics of Chinese patients improved, including nutritional and mineral metabolic parameters.
Besides the differences in patient characteristics, PD practice and dialysis adequacy were significantly different between the two centres. More than 60% of Canadian patients were treated with APD and 30% with the icodextrin solution, whereas all Chinese patients were treated with only CAPD and none was on icodextrin. Another notable difference was a significantly lower PD volume used in Chinese patients. Chinese patients had a smaller body size than their Canadian counterparts but, even allowing for this, the clearances delivered on PD were substantially lower in Chinese patients. Another interesting finding was that Canadian patients had more ultrafiltration than Chinese patients despite higher peritoneal permeability, which may be due to the icodextrin solution and cycler use, and possibly shorter dwell time among CAPD patients with four or more exchanges; however, their urine output was less than that of Chinese patients, resulting in similar daily fluid removal. This observation raised the question whether it is beneficial to allow adequate ultrafiltration at the expense of urine output; Gunal et al. showed that increasing ultrafiltration in CAPD patients could normalize blood pressure but resulted in a striking decrease in urine output [4] . On the other hand, whether Chinese patients were taking a higher dose of diuretics might be another possible explanation for the disproportionately higher urine output; however, data of diuretic use were not available in our study.
Similar to the report from Hong Kong [5] , patient survival of the Chinese cohort in the present study was relatively good even with low doses of PD. Our study showed an almost identical crude patient survival rate between the two centres: 90%, 79%, 72% and 61% for Canadian and 90%, 79%, 71% and 64% for Chinese at 1, 2, 3 and 5 years, respectively. Both centres in the current study seem to have better patient survival than the data of US Renal Data System (USRDS) [6] and Canadian Organ Replacement Register (CORR) [7] but similar to the reports from the more wealthy Asian areas [5, [8] [9] [10] . CVD is a frequent and important cause of morbidity and mortality in patients with ESRD [11, 12] . Thus, it is not surprising that CVD accounted for up to 50% of all deaths in our study. However, while there was a higher prevalence of CVD at the start of PD in the Canadians compared with the Chinese, the number of cardiovascular deaths remained close between the two centres. One limitation of the current study was that it used only historic documentation of comorbid conditions, and quantitative measures for the severity of these conditions were not available. Thus, we do not know whether more Chinese patients developed de novo CVD after PD, or whether they had more aggressive disease. On the other hand, under-diagnosing CVD in Chinese patients could not be completely excluded. Szeto et al. reported that compared to the patients with RRF, anuric patients had a significantly higher CVD mortality, and patients without pre-existing CVD more commonly died of vascular disease after they became anuric [13] . Chinese patients in the present study had lower RRF compared to their Canadian counterparts, and this might partially explain why they had a lower prevalence of CVD at PD initiation but similarly high CVD mortality. Cox regression showed that CVD was associated with a higher risk for death in the Chinese patients than in Canadians, suggesting that the burden of CVD in Chinese patients might be heavier; additional studies are needed to determine optimal measures to prevent or intervene CVD in Chinese patients. On the other hand, Canadian patients had more infection-related deaths, the majority of which were due to peritonitis, indicating the importance of prevention and treatment of such complications in the Canadian patients. In accordance with previous studies [14] [15] [16] , age, CVD, diabetes, RRF and serum albumin were independent determinants of patient survival.
Chinese patients had a higher death-censored technique survival than Canadians. In concordance with other studies [17, 18] , lower BMI and higher serum albumin levels were independent predictors of longer technique survival. Also, we found that female gender was a significant predictor of technique failure. It has been reported recently that females have an almost twice as high likelihood of developing severe peritonitis as males and a greater proportion of them have gram-negative bacilli as the causative organism [19, 20] . This may partially explain our results although we did not find that female patients developed peritonitis earlier than males. The technique survival rate in the present Chinese cohort appears to be as good as, or even better than, that reported from Hong Kong, Japan and Korea [10, [21] [22] [23] . One explanation for the superior technique survival observed in Chinese patients might be their lower peritonitis rate that was remarkably low. Chinese patients had significantly longer peritonitis-free survival than their Canadian counterparts. Secondly, it may be due to the fact that Chinese patients generally were healthier, were younger and had less comorbidity, and so were more able to carry on with PD even in the face of complications such as peritonitis. An alternative explanation is that social reasons may underlie the superior technique survival. A study of CAPD compliance in North America showed that ethnic background was a strong predictor of noncompliance [24] . That is, while 13% of the population as a whole admitted noncompliance, the figure was 9% for Caucasians, 28% for African Americans, but only 3% for Asians. Better compliance may explain at least some of the superior technique survival noted among Chinese patients in this study. Similarly, increased family and social support may produce improved technique survival among Chinese patients [25] . Both centres in the present study have large HD programmes; thus, the availability of HD transfer does not likely explain the difference in technique survival. On the other hand, the threshold for transferring a patient from PD to HD might affect technique survival. However, we don't have data on this aspect of care.
Consistent with other studies [26] [27] [28] , in our study cohort peritonitis not only was the leading cause of technique failure but also contributed to mortality. The Chinese patients had a remarkably lower peritonitis rate than that of Canadian patients. Therefore, the Canadian patients had higher risk of mortality and technique failure due to peritonitis compared to the Chinese patients. Our results confirmed the susceptibility of elderly and hypoalbuminemic patients to peritonitis [29, 30] . Renji centre has a good record system of peritonitis both in computer and charts, and none of the patients in this centre had been trained to intraperitoneal use of antibiotics, being unable to treat themselves when peritonitis occured; therefore, under-reporting likely does not explain the superior peritonitis rate in Chinese patients. We do not know all the factors that contribute to the lower peritonitis rate in the Chinese patients. Perhaps the Chinese patients generally are healthier and have less comorbidity, and so may have stronger defence functions against peritonitis. Another possible explanation is that Chinese patients were dialyzed with fewer exchanges, which might reduce the opportunity of bacteria contamination. In addition, it has been reported that the risk for peritonitis is lower for CAPD than for APD (RR 0.939), which may partially explain the lower peritonitis rate in the Chinese patients [31] . Similar to the technique survival, patient compliance and family support might have a role in the better peritonitis rate in Chinese patients [32] . Finally, genetic factors may explain the differential susceptibility to peritonitis of Canadian and Chinese patients but this remains to be elucidated.
In summary, the present study that compared detailed PD data between one Chinese centre and one Canadian centre showed that patient and treatment characteristics varied between these two centres. Chinese patients were dialyzed with a significantly lower dose. There is no significant difference in mortality between Chinese patients and Canadian patients. Chinese patients had better technique survival both unadjusted and adjusted, probably due to a lower peritonitis rate and generally healthier status than their Canadian counterparts. Several questions might be raised based on these results: Could the peritonitis rate in Canadian patients be improved by concentrating on compliance and possibly fewer exchanges? Will the introduction of the icodextrin solution and cycler dialysis improve the survival in Chinese patients? Clearly additional studies are warranted to address all these questions.
Our study has several obvious limitations. It is a retrospective study and therefore ascertainment error, recall, informative censoring and lead-time biases cannot be avoided. Only one centre each with a limited number of patients from the two countries was included, so it may be difficult to extrapolate the results to all Chinese and Canadian PD patients. Also, we do not know the proportions of patients who started renal replacement therapy with PD in both centres. However, we believe that patients from the two centres do not deviate substantially from the respective national PD population. Although we have analysed relatively detailed information about patient characteristics and practice patterns in survival analysis, other unknown or residual confounders may still exist. In addition, no data are available for other potentially important end points such as deterioration of RRF, cardiovascular events or number of hospitalizations.
We conclude that patient characteristics, dialysis practice patterns and outcomes differed between the Canadian centre and Chinese centre. The difference in patient outcome between centres indicates that further improvements are possible in both centres.
